The Idaho Freedom Foundation & Cannabis Reform

Last verified: April 2026

The Idaho Freedom Foundation

The Idaho Freedom Foundation (IFF) is a conservative policy organization that publishes the "Freedom Index," a legislative scorecard that has become an internal Republican-primary loyalty test. IFF has historically scored cannabis-reform votes negatively, and its allied legislators — sometimes called the "True Idaho" wing of the GOP — have driven prohibitionist votes through committee even where moderate Republicans were prepared to hear medical bills.

The Republican Supermajority

Following the 2024 election cycle the Idaho Senate runs roughly 29 R / 6 D (35 seats) and the Idaho House runs roughly 59 R / 11 D (70 seats). Republicans hold approximately 80% of seats in both chambers — the supermajority required to override gubernatorial vetoes, propose constitutional amendments, and unilaterally control committee assignments.

The "Freedom Index" Effect

IFF's Freedom Index assigns each legislator a percentage score based on votes IFF identifies as advancing or retarding "freedom." Cannabis-reform votes are scored negatively in the IFF framework. The practical consequence:

• Republican legislators face primary challenges from IFF-allied candidates if they receive low Freedom Index scores.
• Voting for cannabis-reform legislation typically produces a negative Freedom Index score.
• An IFF-driven primary challenge can erase a moderate Republican in a single cycle.
• The marginal benefit of a medical-bill sponsorship is low compared to the primary-election risk.

Key Prohibitionist Legislators

• Sen. C. Scott Grow (R-Eagle) — sponsor of HJR 4 (2021), the constitutional entrenchment amendment voters rejected. Senior member of Joint Finance-Appropriations Committee. Continues to oppose any medical-cannabis bill on the Senate floor.
• Rep. Bruce Skaug (R-Nampa) — chair of the House Judiciary, Rules and Administration Committee. Has consistently held cannabis-reform bills in committee without a hearing.
• Senate and House Health & Welfare Committees — historically the "graveyards" where any medical-cannabis legislation has died without hearing or with a quick adverse vote.

Reform-Curious Republicans

A small number of GOP legislators have signaled openness to a narrow medical bill, particularly for terminal pediatric epilepsy and end-of-life pain management. None has yet introduced a viable bill. The political math is unforgiving: an IFF-driven primary challenge can erase a moderate Republican in a single cycle.

Democratic Caucus

The minority caucus — small but media-active — includes Rep. Ilana Rubel (D-Boise) (House Minority Leader through 2024) and Sen. Melissa Wintrow (D-Boise), both of whom have introduced or co-sponsored medical-cannabis legislation. Without committee chairs, however, Democratic bills are usually buried at the chair's discretion.

Gov. Brad Little (R)

Gov. Brad Little, re-elected to a second term in 2022 and term-limited in 2026, has signed every prohibition-tightening bill that has reached his desk and has not vetoed a cannabis-related law since taking office in 2019. He signed HB 126 (the 2021 hemp bill with the 0.0% THC cap) and signed the resolution placing HJR 4 on the ballot. He has stated publicly that he opposes both medical and adult-use cannabis but defers to the legislature on the policy mechanics. ⚠️ The 2026 gubernatorial race is open; track candidates' cannabis positions.

AG Raúl Labrador

Idaho Attorney General Raúl Labrador (elected 2022, formerly U.S. Representative for ID-1) has prioritized drug-trafficking prosecutions, has joined multistate amicus briefs opposing federal cannabis rescheduling, and has supported ISP interdiction programs. He has not publicly engaged with the rescheduling-litigation question of whether Idaho's Schedule I classification would survive a federal Schedule III move; the legal community's working assumption is that Idaho's statutory schedule is independent of the federal schedule and would not change automatically.

The Health & Welfare Graveyard

The structural reality is that any medical-cannabis or psilocybin bill must pass either House or Senate Health & Welfare to reach the floor. Both committees have been chaired by reliably prohibitionist legislators since 2018, and both have a documented practice of refusing hearings. Reform advocates increasingly view the legislative path as foreclosed and concentrate on the initiative path.

SCR 110 (2024) and HB 124 (2024)

Two 2024 actions illustrate the legislative dynamic:

• SCR 110 (2024) — Senate-passed non-binding concurrent resolution reaffirming Idaho's opposition to cannabis legalization at the state and federal level. No legal effect, but cited regularly in committee testimony.
• HB 124 (2024) — Would have legalized supervised psilocybin-assisted therapy along an Oregon Measure 109 model. Received a House Health & Welfare hearing — itself unusual — but failed in committee.